DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
ESTROGENS, CONJUGATED SYNTHETIC A
Search structure
Trade Names:
CENESTIN
SYNTHETIC CONJUGATED ESTROGENS A
Synonyms:
CENESTIN
ESTROGENS,CONJUGATED SYNTHETIC A
SYNTHETIC CONJUGATED ESTROGENS A
SYNTHETIC CONJUGATED ESTROGENS, A
Status:
Approved (1999)
Entry Type:
Small molecule
Molecule Category:
UNKNOWN
UNII:
JM2621P2LS
Pharmacology
Action
Mechanism of Action
Reference
AGONIST
Estrogen receptor agonist
Indications
Mesh Heading
Maximum Phase
Mesh ID
Reference
Related Entries
MCS
2
Analyze Networks
×
Target Level :
Level 3
Level 4
Level 5
Level 6
Extend :
Indication
Mechanism of Action
Primary Target
Target Level
Apply
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA
×
Datasets:
Active Pharmaceutical Ingredients (APIs)
Scaffolds
Search:
SubStructure
Adverse Reactions
SOC By Demographic Distribution
System Organ Classification (SOC)
Relative Frequency (%)
General disorders and administration site conditions
18.32
Reproductive system and breast disorders
12.21
Skin and subcutaneous tissue disorders
11.45
Vascular disorders
9.92
Nervous system disorders
8.4
Psychiatric disorders
7.63
Musculoskeletal and connective tissue disorders
6.11
Gastrointestinal disorders
5.34
Investigations
4.58
Immune system disorders
3.05
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
3.05
Cardiac disorders
2.29
Renal and urinary disorders
2.29
Cross References
Resources
Reference
ChEMBL
CHEMBL1201466
FDA SRS
JM2621P2LS
CONTENTS
Structure
Indications
Related Entries
Adverse Reactions
Cross References
×
Active Pharmaceutical Ingredients (APIs)
Scaffolds
Exact
Similarity
SubStructure
Threshold (%) >=
70